Enanta Pharmaceuticals Announces the Appointment of John P. DeVincenzo, M.D. as Vice President of Translational Virology
Tuesday, January 5th 2021 at 12:01pm UTC Brings More Than 30 Years of Clinical Research and Academic Expertise in Respiratory…
Tuesday, January 5th 2021 at 12:01pm UTC Brings More Than 30 Years of Clinical Research and Academic Expertise in Respiratory…
Tuesday, January 5th 2021 at 12:00pm UTC BOSTON–(BUSINESS WIRE)– Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company…
Tuesday, January 5th 2021 at 11:30am UTC BOSTON–(BUSINESS WIRE)– Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create…
Tuesday, January 5th 2021 at 11:30am UTC BOSTON–(BUSINESS WIRE)– Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create…
Tuesday, January 5th 2021 at 11:30am UTC BOSTON–(BUSINESS WIRE)– Karuna Therapeutics, Inc. (NASDAQ:KRTX), a clinical-stage biopharmaceutical company driven to create…
Thursday, January 7th 2021 at 12:00pm UTC Statistical Significance of Reproxalap Over Vehicle Achieved for Ocular Redness, an FDA-Approvable Sign,…
Thursday, January 7th 2021 at 12:00pm UTC Statistical Significance of Reproxalap Over Vehicle Achieved for Ocular Redness, an FDA-Approvable Sign,…
Thursday, January 7th 2021 at 12:00pm UTC Statistical Significance of Reproxalap Over Vehicle Achieved for Ocular Redness, an FDA-Approvable Sign,…
Thursday, January 7th 2021 at 1:35pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that CEO Adelene…
Thursday, January 7th 2021 at 1:35pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced that CEO Adelene…